HEADER TRANSFERASE 21-MAY-04 1TCV TITLE CRYSTAL STRUCTURE OF THE PURINE NUCLEOSIDE PHOSPHORYLASE FROM TITLE 2 SCHISTOSOMA MANSONI IN COMPLEX WITH NON-DETERGENT SULFOBETAINE 195 TITLE 3 AND ACETATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PURINE-NUCLEOSIDE PHOSPHORYLASE; COMPND 3 CHAIN: A, B, C; COMPND 4 EC: 2.4.2.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCHISTOSOMA MANSONI; SOURCE 3 ORGANISM_TAXID: 6183; SOURCE 4 GENE: SMPNP; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PMAL C2G KEYWDS PURINE NUCLEOSIDE PHOSPHORYLASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.D.PEREIRA,G.R.FRANCO,A.CLEASBY,R.C.GARRATT REVDAT 5 03-APR-24 1TCV 1 REMARK REVDAT 4 14-FEB-24 1TCV 1 REMARK REVDAT 3 24-FEB-09 1TCV 1 VERSN REVDAT 2 01-NOV-05 1TCV 1 AUTHOR JRNL REVDAT 1 24-MAY-05 1TCV 0 JRNL AUTH H.D.PEREIRA,G.R.FRANCO,A.CLEASBY,R.C.GARRATT JRNL TITL STRUCTURES FOR THE POTENTIAL DRUG TARGET PURINE NUCLEOSIDE JRNL TITL 2 PHOSPHORYLASE FROM SCHISTOSOMA MANSONI CAUSAL AGENT OF JRNL TITL 3 SCHISTOSOMIASIS. JRNL REF J.MOL.BIOL. V. 353 584 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16182308 JRNL DOI 10.1016/J.JMB.2005.08.045 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.M.PEREIRA,A.CLEASBY,S.D.PENA,G.R.FRANCO,R.C.GARRATT REMARK 1 TITL CLONING, EXPRESSION AND PRELIMINARY CRYSTALLOGRAPHIC STUDIES REMARK 1 TITL 2 OF THE POTENTIAL DRUG TARGET PURINE NUCLEOSIDE PHOSPHORYLASE REMARK 1 TITL 3 FROM SCHISTOSOMA MANSONI REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 59 1096 2003 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S090744490300773X REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 87.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 74411 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3942 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5158 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE SET COUNT : 274 REMARK 3 BIN FREE R VALUE : 0.2620 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6269 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 725 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.29000 REMARK 3 B22 (A**2) : 0.65000 REMARK 3 B33 (A**2) : -0.94000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.125 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.111 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.073 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.261 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6409 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 6069 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8667 ; 1.154 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): 14137 ; 0.744 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 815 ; 5.362 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1021 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7004 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1160 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1323 ; 0.199 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 7447 ; 0.230 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3970 ; 0.079 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 504 ; 0.122 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.149 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 47 ; 0.276 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 39 ; 0.179 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDIN REMARK 4 REMARK 4 1TCV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1000022546. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-NOV-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : DIAMOND (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 78422 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 45.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : 0.08100 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.35200 REMARK 200 R SYM FOR SHELL (I) : 0.29800 REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: THE STARTING MODEL FOR MOLECULAR REPLACEMENT WAS REMARK 200 THE SMPNP (PURINE NUCLEOSIDE PHOSPHORYLASE FROM S. MANSONI) REMARK 200 REFINED AT 2.75 A RESOLUTION. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 1500, GLYCEROL, ACETETE BUFFER, REMARK 280 NON-DETERGENT SULFOBETAINE 195, PH 5.0, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K, PH 5.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.37750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.88050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 61.02950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.88050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.37750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 61.02950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 HIS A 2 REMARK 465 VAL A 63 REMARK 465 VAL A 64 REMARK 465 GLY A 65 REMARK 465 LEU A 255 REMARK 465 LYS A 256 REMARK 465 PRO A 257 REMARK 465 ASN A 258 REMARK 465 HIS A 259 REMARK 465 GLU A 260 REMARK 465 GLU A 261 REMARK 465 VAL A 262 REMARK 465 LEU A 263 REMARK 465 ALA A 264 REMARK 465 THR A 265 REMARK 465 MET B 1 REMARK 465 HIS B 2 REMARK 465 GLU B 3 REMARK 465 VAL B 63 REMARK 465 VAL B 64 REMARK 465 GLY B 65 REMARK 465 HIS B 66 REMARK 465 ASP B 254 REMARK 465 LEU B 255 REMARK 465 LYS B 256 REMARK 465 PRO B 257 REMARK 465 ASN B 258 REMARK 465 HIS B 259 REMARK 465 MET C 1 REMARK 465 HIS C 2 REMARK 465 GLU C 3 REMARK 465 SER C 62 REMARK 465 VAL C 63 REMARK 465 VAL C 64 REMARK 465 GLY C 65 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 62 OG REMARK 470 HIS A 66 CG ND1 CD2 CE1 NE2 REMARK 470 SER B 4 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 182 O HOH A 1071 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 46 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 4 -172.17 66.14 REMARK 500 ASN A 57 -5.47 74.98 REMARK 500 LEU A 145 14.85 80.55 REMARK 500 PHE A 161 79.83 -117.72 REMARK 500 THR A 223 -49.20 77.34 REMARK 500 ASN B 57 -3.94 69.69 REMARK 500 PHE B 161 78.98 -118.52 REMARK 500 THR B 223 -55.83 81.29 REMARK 500 GLU B 252 18.31 93.75 REMARK 500 LEU C 145 17.97 82.86 REMARK 500 THR C 223 -50.29 77.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT C 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDS A 951 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDS B 952 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDS C 953 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TCU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PURINE NUCLEOSIDE PHOSPHORYLASE FROM REMARK 900 SCHISTOSOMA MANSONI IN COMPLEX WITH PHOSPHATE AND ACETATE REMARK 900 RELATED ID: 1TD1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PURINE NUCLEOSIDE PHOSPHORYLASE FROM REMARK 900 SCHISTOSOMA MANSONI IN COMPLEX WITH ACETATE DBREF 1TCV A 1 287 UNP Q9BMI9 Q9BMI9_SCHMA 1 287 DBREF 1TCV B 1 287 UNP Q9BMI9 Q9BMI9_SCHMA 1 287 DBREF 1TCV C 1 287 UNP Q9BMI9 Q9BMI9_SCHMA 1 287 SEQRES 1 A 287 MET HIS GLU SER VAL THR ALA ASN ILE GLU ASN VAL LYS SEQRES 2 A 287 LYS VAL ALA HIS HIS ILE GLN LYS LEU THR SER ILE VAL SEQRES 3 A 287 PRO GLU ILE GLY ILE ILE CYS GLY SER GLY LEU GLY LYS SEQRES 4 A 287 LEU ALA ASP GLY VAL LYS ASP LYS ILE THR ILE PRO TYR SEQRES 5 A 287 THR LYS ILE PRO ASN PHE PRO GLN THR SER VAL VAL GLY SEQRES 6 A 287 HIS SER GLY ASN LEU ILE PHE GLY THR LEU SER GLY ARG SEQRES 7 A 287 LYS VAL VAL VAL MET GLN GLY ARG PHE HIS MET TYR GLU SEQRES 8 A 287 GLY TYR SER ASN ASP THR VAL ALA LEU PRO ILE ARG VAL SEQRES 9 A 287 MET LYS LEU LEU GLY VAL LYS ILE LEU MET VAL SER ASN SEQRES 10 A 287 ALA ALA GLY GLY LEU ASN ARG SER LEU LYS LEU GLY ASP SEQRES 11 A 287 PHE VAL ILE LEU LYS ASP HIS ILE TYR LEU PRO GLY LEU SEQRES 12 A 287 GLY LEU ASN ASN ILE LEU VAL GLY PRO ASN GLN GLU ALA SEQRES 13 A 287 PHE GLY THR ARG PHE PRO ALA LEU SER ASN ALA TYR ASP SEQRES 14 A 287 ARG ASP LEU ARG LYS LEU ALA VAL GLN VAL ALA GLU GLU SEQRES 15 A 287 ASN GLY PHE GLY ASN LEU VAL HIS GLN GLY VAL TYR VAL SEQRES 16 A 287 MET ASN GLY GLY PRO CYS TYR GLU THR PRO ALA GLU CYS SEQRES 17 A 287 THR MET LEU LEU ASN MET GLY CYS ASP VAL VAL GLY MET SEQRES 18 A 287 SER THR ILE PRO GLU VAL VAL ILE ALA ARG HIS CYS GLY SEQRES 19 A 287 ILE GLN VAL PHE ALA VAL SER LEU VAL THR ASN ILE SER SEQRES 20 A 287 VAL LEU ASP VAL GLU SER ASP LEU LYS PRO ASN HIS GLU SEQRES 21 A 287 GLU VAL LEU ALA THR GLY ALA GLN ARG ALA GLU LEU MET SEQRES 22 A 287 GLN SER TRP PHE GLU LYS ILE ILE GLU LYS LEU PRO LYS SEQRES 23 A 287 ASP SEQRES 1 B 287 MET HIS GLU SER VAL THR ALA ASN ILE GLU ASN VAL LYS SEQRES 2 B 287 LYS VAL ALA HIS HIS ILE GLN LYS LEU THR SER ILE VAL SEQRES 3 B 287 PRO GLU ILE GLY ILE ILE CYS GLY SER GLY LEU GLY LYS SEQRES 4 B 287 LEU ALA ASP GLY VAL LYS ASP LYS ILE THR ILE PRO TYR SEQRES 5 B 287 THR LYS ILE PRO ASN PHE PRO GLN THR SER VAL VAL GLY SEQRES 6 B 287 HIS SER GLY ASN LEU ILE PHE GLY THR LEU SER GLY ARG SEQRES 7 B 287 LYS VAL VAL VAL MET GLN GLY ARG PHE HIS MET TYR GLU SEQRES 8 B 287 GLY TYR SER ASN ASP THR VAL ALA LEU PRO ILE ARG VAL SEQRES 9 B 287 MET LYS LEU LEU GLY VAL LYS ILE LEU MET VAL SER ASN SEQRES 10 B 287 ALA ALA GLY GLY LEU ASN ARG SER LEU LYS LEU GLY ASP SEQRES 11 B 287 PHE VAL ILE LEU LYS ASP HIS ILE TYR LEU PRO GLY LEU SEQRES 12 B 287 GLY LEU ASN ASN ILE LEU VAL GLY PRO ASN GLN GLU ALA SEQRES 13 B 287 PHE GLY THR ARG PHE PRO ALA LEU SER ASN ALA TYR ASP SEQRES 14 B 287 ARG ASP LEU ARG LYS LEU ALA VAL GLN VAL ALA GLU GLU SEQRES 15 B 287 ASN GLY PHE GLY ASN LEU VAL HIS GLN GLY VAL TYR VAL SEQRES 16 B 287 MET ASN GLY GLY PRO CYS TYR GLU THR PRO ALA GLU CYS SEQRES 17 B 287 THR MET LEU LEU ASN MET GLY CYS ASP VAL VAL GLY MET SEQRES 18 B 287 SER THR ILE PRO GLU VAL VAL ILE ALA ARG HIS CYS GLY SEQRES 19 B 287 ILE GLN VAL PHE ALA VAL SER LEU VAL THR ASN ILE SER SEQRES 20 B 287 VAL LEU ASP VAL GLU SER ASP LEU LYS PRO ASN HIS GLU SEQRES 21 B 287 GLU VAL LEU ALA THR GLY ALA GLN ARG ALA GLU LEU MET SEQRES 22 B 287 GLN SER TRP PHE GLU LYS ILE ILE GLU LYS LEU PRO LYS SEQRES 23 B 287 ASP SEQRES 1 C 287 MET HIS GLU SER VAL THR ALA ASN ILE GLU ASN VAL LYS SEQRES 2 C 287 LYS VAL ALA HIS HIS ILE GLN LYS LEU THR SER ILE VAL SEQRES 3 C 287 PRO GLU ILE GLY ILE ILE CYS GLY SER GLY LEU GLY LYS SEQRES 4 C 287 LEU ALA ASP GLY VAL LYS ASP LYS ILE THR ILE PRO TYR SEQRES 5 C 287 THR LYS ILE PRO ASN PHE PRO GLN THR SER VAL VAL GLY SEQRES 6 C 287 HIS SER GLY ASN LEU ILE PHE GLY THR LEU SER GLY ARG SEQRES 7 C 287 LYS VAL VAL VAL MET GLN GLY ARG PHE HIS MET TYR GLU SEQRES 8 C 287 GLY TYR SER ASN ASP THR VAL ALA LEU PRO ILE ARG VAL SEQRES 9 C 287 MET LYS LEU LEU GLY VAL LYS ILE LEU MET VAL SER ASN SEQRES 10 C 287 ALA ALA GLY GLY LEU ASN ARG SER LEU LYS LEU GLY ASP SEQRES 11 C 287 PHE VAL ILE LEU LYS ASP HIS ILE TYR LEU PRO GLY LEU SEQRES 12 C 287 GLY LEU ASN ASN ILE LEU VAL GLY PRO ASN GLN GLU ALA SEQRES 13 C 287 PHE GLY THR ARG PHE PRO ALA LEU SER ASN ALA TYR ASP SEQRES 14 C 287 ARG ASP LEU ARG LYS LEU ALA VAL GLN VAL ALA GLU GLU SEQRES 15 C 287 ASN GLY PHE GLY ASN LEU VAL HIS GLN GLY VAL TYR VAL SEQRES 16 C 287 MET ASN GLY GLY PRO CYS TYR GLU THR PRO ALA GLU CYS SEQRES 17 C 287 THR MET LEU LEU ASN MET GLY CYS ASP VAL VAL GLY MET SEQRES 18 C 287 SER THR ILE PRO GLU VAL VAL ILE ALA ARG HIS CYS GLY SEQRES 19 C 287 ILE GLN VAL PHE ALA VAL SER LEU VAL THR ASN ILE SER SEQRES 20 C 287 VAL LEU ASP VAL GLU SER ASP LEU LYS PRO ASN HIS GLU SEQRES 21 C 287 GLU VAL LEU ALA THR GLY ALA GLN ARG ALA GLU LEU MET SEQRES 22 C 287 GLN SER TRP PHE GLU LYS ILE ILE GLU LYS LEU PRO LYS SEQRES 23 C 287 ASP HET ACT A 900 4 HET NDS A 951 12 HET ACT B 901 4 HET NDS B 952 12 HET ACT C 902 4 HET NDS C 953 12 HETNAM ACT ACETATE ION HETNAM NDS ETHYL DIMETHYL AMMONIO PROPANE SULFONATE FORMUL 4 ACT 3(C2 H3 O2 1-) FORMUL 5 NDS 3(C7 H17 N O3 S) FORMUL 10 HOH *725(H2 O) HELIX 1 1 ASN A 8 THR A 23 1 16 HELIX 2 2 LEU A 37 ASP A 42 5 6 HELIX 3 3 THR A 53 ILE A 55 5 3 HELIX 4 4 HIS A 88 GLY A 92 5 5 HELIX 5 5 SER A 94 GLY A 109 1 16 HELIX 6 6 LEU A 140 GLY A 144 1 5 HELIX 7 7 ASP A 169 ASN A 183 1 15 HELIX 8 8 PHE A 185 ASN A 187 5 3 HELIX 9 9 THR A 204 MET A 214 1 11 HELIX 10 10 THR A 223 CYS A 233 1 11 HELIX 11 11 GLY A 266 LEU A 284 1 19 HELIX 12 12 ASN B 8 THR B 23 1 16 HELIX 13 13 LYS B 39 VAL B 44 5 6 HELIX 14 14 THR B 53 ILE B 55 5 3 HELIX 15 15 HIS B 88 GLY B 92 5 5 HELIX 16 16 SER B 94 GLY B 109 1 16 HELIX 17 17 LEU B 140 GLY B 144 1 5 HELIX 18 18 ASP B 169 ASN B 183 1 15 HELIX 19 19 PHE B 185 ASN B 187 5 3 HELIX 20 20 THR B 204 MET B 214 1 11 HELIX 21 21 THR B 223 CYS B 233 1 11 HELIX 22 22 GLU B 260 LYS B 283 1 24 HELIX 23 23 ASN C 8 THR C 23 1 16 HELIX 24 24 LYS C 39 VAL C 44 1 6 HELIX 25 25 THR C 53 ILE C 55 5 3 HELIX 26 26 HIS C 88 GLY C 92 5 5 HELIX 27 27 SER C 94 GLY C 109 1 16 HELIX 28 28 LEU C 140 GLY C 144 1 5 HELIX 29 29 ASP C 169 ASN C 183 1 15 HELIX 30 30 PHE C 185 ASN C 187 5 3 HELIX 31 31 THR C 204 MET C 214 1 11 HELIX 32 32 THR C 223 CYS C 233 1 11 HELIX 33 33 ASN C 258 LEU C 284 1 27 SHEET 1 A10 LYS A 45 PRO A 51 0 SHEET 2 A10 ASN A 69 LEU A 75 -1 O LEU A 70 N ILE A 50 SHEET 3 A10 ARG A 78 GLN A 84 -1 O VAL A 80 N GLY A 73 SHEET 4 A10 ILE A 29 ILE A 32 1 N ILE A 31 O MET A 83 SHEET 5 A10 ILE A 112 GLY A 121 1 O MET A 114 N GLY A 30 SHEET 6 A10 GLN A 236 ILE A 246 1 O GLN A 236 N LEU A 113 SHEET 7 A10 PHE A 131 TYR A 139 -1 N LEU A 134 O ALA A 239 SHEET 8 A10 VAL A 189 MET A 196 1 O HIS A 190 N ILE A 133 SHEET 9 A10 VAL A 218 GLY A 220 1 O VAL A 218 N VAL A 195 SHEET 10 A10 ILE A 112 GLY A 121 -1 N GLY A 120 O VAL A 219 SHEET 1 B10 LYS B 45 PRO B 51 0 SHEET 2 B10 ASN B 69 LEU B 75 -1 O LEU B 70 N ILE B 50 SHEET 3 B10 ARG B 78 GLN B 84 -1 O GLN B 84 N ASN B 69 SHEET 4 B10 ILE B 29 ILE B 32 1 N ILE B 31 O MET B 83 SHEET 5 B10 ILE B 112 GLY B 121 1 O ILE B 112 N GLY B 30 SHEET 6 B10 GLN B 236 ILE B 246 1 O ASN B 245 N GLY B 121 SHEET 7 B10 PHE B 131 TYR B 139 -1 N LEU B 134 O ALA B 239 SHEET 8 B10 VAL B 189 MET B 196 1 O HIS B 190 N ILE B 133 SHEET 9 B10 VAL B 218 GLY B 220 1 O VAL B 218 N VAL B 195 SHEET 10 B10 ILE B 112 GLY B 121 -1 N GLY B 120 O VAL B 219 SHEET 1 C10 LYS C 45 PRO C 51 0 SHEET 2 C10 ASN C 69 LEU C 75 -1 O LEU C 70 N ILE C 50 SHEET 3 C10 ARG C 78 GLN C 84 -1 O VAL C 80 N GLY C 73 SHEET 4 C10 ILE C 29 ILE C 32 1 N ILE C 31 O MET C 83 SHEET 5 C10 ILE C 112 GLY C 121 1 O ILE C 112 N GLY C 30 SHEET 6 C10 GLN C 236 ILE C 246 1 O GLN C 236 N LEU C 113 SHEET 7 C10 PHE C 131 TYR C 139 -1 N VAL C 132 O SER C 241 SHEET 8 C10 VAL C 189 MET C 196 1 O HIS C 190 N ILE C 133 SHEET 9 C10 VAL C 218 GLY C 220 1 O VAL C 218 N VAL C 195 SHEET 10 C10 ILE C 112 GLY C 121 -1 N GLY C 120 O VAL C 219 CISPEP 1 GLY A 199 PRO A 200 0 6.75 CISPEP 2 GLY B 199 PRO B 200 0 8.37 CISPEP 3 GLY C 199 PRO C 200 0 6.74 SITE 1 AC1 9 ALA A 119 GLY A 120 TYR A 202 GLU A 203 SITE 2 AC1 9 VAL A 219 GLY A 220 MET A 221 ASN A 245 SITE 3 AC1 9 NDS A 951 SITE 1 AC2 8 ALA B 119 GLY B 120 TYR B 202 GLU B 203 SITE 2 AC2 8 VAL B 219 GLY B 220 ASN B 245 NDS B 952 SITE 1 AC3 7 ALA C 119 GLY C 120 TYR C 202 GLU C 203 SITE 2 AC3 7 VAL C 219 ASN C 245 NDS C 953 SITE 1 AC4 11 GLY A 34 SER A 35 ARG A 86 HIS A 88 SITE 2 AC4 11 ASN A 117 ALA A 118 TYR A 202 SER A 222 SITE 3 AC4 11 ACT A 900 HOH A1016 PHE B 161 SITE 1 AC5 13 SER B 35 ARG B 86 HIS B 88 TYR B 90 SITE 2 AC5 13 ASN B 117 ALA B 118 TYR B 202 MET B 221 SITE 3 AC5 13 SER B 222 VAL B 262 ACT B 901 HOH B 966 SITE 4 AC5 13 PHE C 161 SITE 1 AC6 14 PHE A 161 ARG C 86 HIS C 88 TYR C 90 SITE 2 AC6 14 ALA C 118 TYR C 202 MET C 221 SER C 222 SITE 3 AC6 14 THR C 244 VAL C 262 ACT C 902 HOH C 987 SITE 4 AC6 14 HOH C1031 HOH C1050 CRYST1 48.755 122.059 129.761 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020511 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008193 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007706 0.00000